AK, B., JN, E., KA, H., M, B., MC, M., S, E., & WB, B. (2026). Personalized ADHD Medication Experiments to Inform Decisions About Continued Medication Use: An Open-Label Trial. Academic pediatrics, 26(3), 103250. https://doi.org/10.1016/j.acap.2026.103250
Chicago Style (17th ed.) CitationAK, Banister, Epstein JN, Hommel KA, Breslin M, MacDougall MC, Ehrlich S, and Brinkman WB. "Personalized ADHD Medication Experiments to Inform Decisions About Continued Medication Use: An Open-Label Trial." Academic Pediatrics 26, no. 3 (2026): 103250. https://doi.org/10.1016/j.acap.2026.103250.
MLA (9th ed.) CitationAK, Banister, et al. "Personalized ADHD Medication Experiments to Inform Decisions About Continued Medication Use: An Open-Label Trial." Academic Pediatrics, vol. 26, no. 3, 2026, p. 103250, https://doi.org/10.1016/j.acap.2026.103250.